Table of contents
July 2005 Vol 4 No 7
In this issue
p521 | doi:10.1038/nrd1795
Editorial: Incentive to be inventive
p523 | doi:10.1038/nrd1788
News and Analysis
Big companies helped by safe harbour ruling | PDF (213 KB)
p525 | doi:10.1038/nrd1789
Caution remains over stem cells despite breakthrough | PDF (154 KB)
p527 | doi:10.1038/nrd1790
News in Brief
Registering drug trials on trial | European court shies away from parallel trading | More concerns with Tysabri | Senate approves FDA head nomination | Another purchase for Pfizer | Viagra link to blindness | Clotting drug response in the genes | CV risk for NSAIDs? | PDF (325 KB)
p528 | doi:10.1038/nrd1791
Patent watch
EC fines AstraZeneca in Losec antitrust case | PDF (47 KB)
p530 | doi:10.1038/nrd1792
Patent watch
Pharma allowed to make own generics | PDF (36 KB)
p530 | doi:10.1038/nrd1793
Patent primer
Added matter and patentability | PDF (59 KB)
p531 | doi:10.1038/nrd1781
Career Path
Susan Desmond-Hellmann | PDF (73 KB)
p532 | doi:10.1038/nrd1794
From the analyst's couch
Valuation with cash multiples | PDF (161 KB)
p533 | doi:10.1038/nrd1779
Fresh from the Pipeline
Entecavir | PDF (139 KB)
p535 | doi:10.1038/nrd1780
Research Highlights
Drug delivery: Transferrin' the load | PDF (135 KB)
p537 | doi:10.1038/nrd1786
Bacterial sepsis: Pepducins to the rescue | PDF (305 KB)
p538 | doi:10.1038/nrd1782
Infectious diseases: Double trouble | PDF (161 KB)
p538 | doi:10.1038/nrd1784
Lead discovery: Cell death by design | PDF (205 KB)
p539 | doi:10.1038/nrd1785
In brief
Anxiety disorders | HIV | Gene expression | PDF (189 KB)
p540 | doi:10.1038/nrd1783
Medicinal chemistry: Best of both worlds? | PDF (189 KB)
p540 | doi:10.1038/nrd1787
Perspectives
Essay
Monitoring the safety of licensed medicines
Alasdair Breckenridge, Kent Woods & June Raine
p541 | doi:10.1038/nrd1778
Reviews
Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates
Ernst R. Berndt, Adrian H. B. Gottschalk, Tomas J. Philipson & Matthew W. Strobeck
p545 | doi:10.1038/nrd1774
Solid-state NMR in drug design and discovery for membrane-embedded targets
Anthony Watts
p555 | doi:10.1038/nrd1773
Ageing and metabolism: drug discovery opportunities
Rory Curtis, Bard J. Geesaman & Peter S. DiStefano
p569 | doi:10.1038/nrd1777
Design and development of polymers for gene delivery
Daniel W. Pack, Allan S. Hoffman, Suzie Pun & Patrick S. Stayton
p581 | doi:10.1038/nrd1775
The emerging field of lipidomics
Markus R. Wenk
p594 | doi:10.1038/nrd1776
